SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CGNE CALGENE
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bhag Karamchandani who wrote (8)11/12/1996 12:47:00 AM
From: aknahow   of 76
 
No estimate on projected losses. As you seem to imply with your question, there is probably no incentive for Monsanto to increase stock price. They do have incentive to return company to profitability since there will be some sort of consolidation of results. If CGNE produces profits stock might rise irrespective of value of price increase to Monsanto if their objective is to obtain 100% interest. See company trading in range of $4 to $10 over next 3 to 5 years depending on how market see takeover prospects. Long shot is outside bid to Monsanto for its controling interest with subsequent offer to minority holders. Such a bid in my opinion could come from German, Swiss or Japanese Agro-Chemical Co. Swiss bought up number of seed cos years ago. Think market quickly figured out that upside was limited when Monsanto first bailed them out. Europes boycott of genitically enhanced soybeans is also a negative re other altered grains.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News